YUESAI BIOTECHNOLOGY
Yuesai Biotechnology is a new-generation cell therapy drug developer, focusing on the development of a new generation of cell therapy drugs.
YUESAI BIOTECHNOLOGY
Industry:
Biotechnology
Founded:
1970
Address:
Pudong, Shandong, China
Country:
China
Total Employee:
11+
Status:
Active
Total Funding:
200 M CNY
Investors List
KUNLUN
KUNLUN investment in Seed Round - Yuesai Biotechnology
TF Capital
TF Capital investment in Seed Round - Yuesai Biotechnology
Fosun Pharma
Fosun Pharma investment in Seed Round - Yuesai Biotechnology
Ruihua Venture Capital
Ruihua Venture Capital investment in Seed Round - Yuesai Biotechnology
CDH Investments
CDH Investments investment in Seed Round - Yuesai Biotechnology
Hillhouse Capital Group
Hillhouse Capital Group investment in Seed Round - Yuesai Biotechnology
Sherpa Venture Capital
Sherpa Venture Capital investment in Seed Round - Yuesai Biotechnology
More informations about "Yuesai Biotechnology" on Search Engine
Yuesai Biotechnology - Crunchbase Company Profile & Funding
Yuesai Biotechnology is a cell therapy drug developer that uses human pluripotent stem cell technology. Yuesai Biotechnology develops stem cell therapy for …See details»
Yuesai Biotechnology Company Profile: Valuation & Investors
Aug 25, 2021 Yuesai Biotechnology General Information. Description. Developer of cellular therapy based on human pluripotent stem cells. The company develops stem cell therapy, committing to cure neurodegenerative diseases, rare diseases and tumors. Contact Information. Ownership Status. Privately Held (backing)See details»
Yuesai biology obtained nearly 200 million yuan of pre-A round of ...
Mar 14, 2022 Healthcare Mar 14, 2022 09:38 AM (GMT+8) · EqualOcean On March 14, Shanghai yuesai Biotechnology Co., Ltd. (hereinafter referred to as "yuesai biology"), a …See details»
Yuesai - L'Oréal Group - L'Oréal Luxe Division
Yuesai believes in the powerful properties and wisdom of TCM (Traditional Chinese Medicine) for both beauty & wellness. Taking the most precious TCM, like the finest Ganoderma from Huoshan, Cordyceps from Qinghai, …See details»
Shanghai Yuesai Biotechnology Co., Ltd. announced that it has …
May 25, 2023 Shanghai Yuesai Biotechnology Co., Ltd. announced that it has received $31,500,000 in a round of funding co-led by ACME, LLC and CDH Investment …See details»
Yuesai Biology | VentureRadar
Yuesai Biology is an enterprise focusing on the development of a new generation of cell therapy drugs based on human pluripotent stem cell technology. It is committed to technology research and product development in the field of stem cell therapy. Its R&D pipeline covers neurodegenerative diseases and rare diseases and tumors.See details»
Yuesai Biotechnology - Updates, News, Events, Signals & Triggers
Edit Recent News & Activity Section. Funding Round • Mar 14, 2022. Yuesai Biotechnology raised CN¥200,000,000 / Seed from CDH Investments and 6 other investorsSee details»
Another Breakthrough For The Group In China: After Mininurse, …
Find all the Press Releases from L'Oréal Groupe about Group: Another Breakthrough For The Group In China: After Mininurse, L’Oreal Acquires Yue-Sai.See details»
Seed Round - Yuesai Biotechnology - 2022-03-14
Mar 14, 2022 Yuesai Biotechnology raised $31419370 on 2022-03-14 in Seed Round. Start Free TrialSee details»
Suozhi Biotechnology (Zhejiang) Co., Ltd. inc. | VentureRadar
Nuwacell Biotechnologies China n/a Nuwacell Biotechnology CO., Ltd (Anhui, P.R. China) was founded by Dr. Junying Yu, a world-famous scientist and one of the inventors of human induced pluripotent stem cells (hiPSC). Nuwacell is a high-tech enterprise focusing on hiPSC research and clinical transformation, and is committed to becoming the leading …See details»
Yuesai Biotechnology - Headquarter Location, Corporate Office …
Yuesai Biotechnology is Drug Discovery in China that focus on developer business. Founded in 2021. They cover business area such as developer, cellular therapy, human …See details»
Yuesai Biotechnology has 1 Funding Round from 7 Investors
Yuesai Biotechnology has 1 Funding Round from 7 Investors. Save Search . Companies Contacts Investors Funding Rounds Acquisitions People Events Schools Hubs Saved . Organization Name . Add Funding Rounds filter . includes any. Operator.See details»
Fosun Pharma - Funding, Financials, Valuation & Investors
May 18, 2023 Highlights Lead Investments 15 Investments 31 Exits 11 Funding Fosun Pharma is registered under the ticker HKG:2196 . Fosun Pharma has made 31 investments. Their most recent investment was on …See details»
Shanghai Yuesai Biotechnology | Evaluate
April 26, 2023 Tecentriq runs out of luck in triple-negative breast cancer Roche puts on a brave face as its anti-PD-L1 drug fails yet another TNBC study, this time in the adjuvant …See details»
The Second Generation of Yuesai Gold-plated Bottle Essence
May 9, 2022 As a gilded CP, YUESAI and Li Jiaqi jointly created a new YUESAI gilded liquid foundation. This is the brand's first high-coverage skincare foundation. Selected …See details»
National Center for Biotechnology Information
Before sharing sensitive information, make sure you're on a federal government site. The site is secure. ... The National Center for Biotechnology Information advances science and health by providing access to biomedical and genomic information.See details»
Biotechnology | Definition, Examples, & Applications | Britannica
Biotechnology, the use of biology to solve problems and make useful products. The most prominent area of biotechnology is the production of therapeutic proteins and other drugs through genetic engineering. …See details»
Yue-Sai Cosmetics Company Profile: Acquisition & Investors
Yue-Sai Cosmetics General Information. Description. Manufacturer and distributor of cosmetics and beauty products. The company's products include skin care, facial care, eye care, lip care and makeup products. Contact Information. site. www.yuesai.com. Ownership Status. Acquired/MergedSee details»
YUESAI Rejuvenate Cordyceps Personalized Serum - Fine …
Sep 15, 2019 YUESAI Rejuvenate Cordyceps Personalized Serum - Fine ingredients explained: Aqua, Propylene Glycol, Bifida Ferment Lysate, Glycerin, Dipropylene Glycol, Propanediol, PEG/PPG/Polybutylene Glycol-8/5/3 Glycerin, Hydroxypropyl Tetrahydropyrantriol, Salicylic Acid, Capryloyl Glycine, Bis-PEG-18 Methyl Ether …See details»
CDH Investments - Recent News & Activity
Apr 7, 2023 Yuesai Biotechnology raised CN¥200,000,000 / Seed from CDH Investments and 6 other investors . Discover more funding rounds . ... Mission Information …See details»